Global Home Parenteral Nutrition (HPN) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Home Parenteral Nutrition (HPN) Market Research Report 2024
Home parenteral nutrition (HPN) refers to long-term feeding methods that directly administer essential nutrients into the bloodstream via peripheral venous access devices like midlines, portacatheters, or implanted ports instead of eating and digesting ordinary foods orally.
According to Mr Accuracy reports new survey, global Home Parenteral Nutrition (HPN) market is projected to reach US$ 1219.5 million in 2029, increasing from US$ 804 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Home Parenteral Nutrition (HPN) market research.
The global Home Parenteral Nutrition (HPN) market has been growing steadily in recent years, driven primarily by advancements in technology and increased awareness about the benefits of HPN. However, there have also been challenges faced by companies operating within the space, including regulatory hurdles and competition from alternative forms of treatment.
The market growth can be attributed to rising incidence rates of malnutrition among patients suffering from chronic diseases such as cancer and liver failures, expanding geriatric population with fragile immune systems requiring external nutritional support, and favorable reimbursement scenarios in developed regions worldwide promoting wider adoption of HPN solutions.
The future outlook for the HPN market appears positive given the increasing number of indications covered by HPN, development of new products capable of addressing unmet needs, and strengthening partnerships between key players and third parties to foster better care pathway coordination across diverse territories with varying regulatory environments impacting product availability. With increasing emphasis placed on precision medicine approaches involving personalized nutrition.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Home Parenteral Nutrition (HPN) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Baxter
Takeda
Pfizer
B. Braun Melsungen
Grifols International
Fresenius Kabi
Otsuka Pharmaceutical
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Neonates
Geriatrics
Chronic Disease Patients
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Home Parenteral Nutrition (HPN) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Home Parenteral Nutrition (HPN) market is projected to reach US$ 1219.5 million in 2029, increasing from US$ 804 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Home Parenteral Nutrition (HPN) market research.
The global Home Parenteral Nutrition (HPN) market has been growing steadily in recent years, driven primarily by advancements in technology and increased awareness about the benefits of HPN. However, there have also been challenges faced by companies operating within the space, including regulatory hurdles and competition from alternative forms of treatment.
The market growth can be attributed to rising incidence rates of malnutrition among patients suffering from chronic diseases such as cancer and liver failures, expanding geriatric population with fragile immune systems requiring external nutritional support, and favorable reimbursement scenarios in developed regions worldwide promoting wider adoption of HPN solutions.
The future outlook for the HPN market appears positive given the increasing number of indications covered by HPN, development of new products capable of addressing unmet needs, and strengthening partnerships between key players and third parties to foster better care pathway coordination across diverse territories with varying regulatory environments impacting product availability. With increasing emphasis placed on precision medicine approaches involving personalized nutrition.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Home Parenteral Nutrition (HPN) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
Takeda
Pfizer
B. Braun Melsungen
Grifols International
Fresenius Kabi
Otsuka Pharmaceutical
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segment by Application
Neonates
Geriatrics
Chronic Disease Patients
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Home Parenteral Nutrition (HPN) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices